Evidence map›Paper›PMID 21432373›Full record

ArticleEnvironmental health and preventive medicine2006

Risk of transmission of imipenem-resistantPseudomonas aeruginosa through use of mobile bathing service.

Naomi Sakurai-Komada, Masako Hirano, Ikumi Nagata, Yumi Ejima, Michiko Nakamura, Kazuko A Koike

Abstract read
In one paragraph

Article in Environmental health and preventive medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Prevalence and antimicrobial-resistance of Pseudomonas aeruginosa in swimming pools and hot tubs.International journal of environmental research and public health · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Naomi Sakurai-KomadaCenter for Medical Sciences School of Health Sciences, Ibaraki Prefectural University of Health Sciences, 4669-2 Ami, 300-0394, Inashiki, Ibaraki, Japan, sakurai@ipu.ac.jp.
Masako Hirano
Ikumi Nagata
Yumi Ejima
Michiko Nakamura
Kazuko A Koike

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe demand for mobile bathing service (MBS) is increasing in the Japanese society. Therefore, we assessed the risk of MBS-associated infection in MBS clients and their caregivers by examining the bacterial colonization of MBS equipment and utensils.

methodsBacterial isolates collected by the stamp agar culture method were examined by disk diffusion assay for their susceptibility to the following drugs: imipenem, ciprofloxacin, amikacin, azutreonam, ceftazidim, meropenem, piperacillin, tobramycin, ofloxacin and cefoperazone. Furthermore, these isolates were subtyped bySpeI-pulsed field gel electrophoresis (SpeI-PFGE).

resultsFifty-fourP. aeruginosa isolates were recovered from different sampling sites, and of these, 26 (47.3%) were isolated from pillows. Eighteen isolates (33.3%) were imipenem (IPM) resistant. The minimum inhibitory concentrations (MICs) of 17 isolates were between 16 and 32 μg/ml, and the MIC of one isolate was greater than 32 μg/ml. TheSpeI-PFGE typing of IPM-resistant isolates revealed that 13 of the 18 isolates were closely related (F=1.0-0.87).

conclusionOur findings suggest that MBS equipment and utensils, particularly pillows, are the primary sources of bacterial contamination and transmission and that there is a risk of MBS-mediated infection among MBS clients and their caregivers.

Indexed as

imipenem-resistantPseudomonas aeruginosalong-term care insuranceMBS-mediated infectionsMBS utensilsmobile bathing service (MBS)

Identifiers

PMID21432373
PMCPMC2723618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.